References to Yamasa Rat/Mouse SP-D Kit EIA II - Surfactant Protein D ELISA

Yamasa Rat/Mouse SP-D Kit EIA II - Surfactant Protein D ELISA Product Citations

Yamasa Rat/Mouse SP-D Kit EIA II, developed and manufactured in Japan by Yamasa Corporation, and distributed by Ilex Life Sciences, has been widely referenced in scientific literature. Below you will find some of the scientific papers that reference Yamasa Rat/Mouse SP-D Kit EIA II.

For more information, please visit the Yamasa Rat/Mouse SP-D Kit EIA II Product Page.

Kondo, Masahiro et al. “Dersimelagon, a novel oral melanocortin 1 receptor agonist, demonstrates disease-modifying effects in preclinical models of systemic sclerosis.” Arthritis research & therapy vol. 24,1 210. 1 Sep. 2022, doi:10.1186/s13075-022-02899-3

Mikami, Shintaro et al. “Nintedanib induces gene expression changes in the lung of induced-rheumatoid arthritis-associated interstitial lung disease mice.” PloS one vol. 17,6 e0270056. 17 Jun. 2022, doi:10.1371/journal.pone.0270056

Takeda, Tomoki et al. “Dose-response relationship of pulmonary disorders by inhalation exposure to cross-linked water-soluble acrylic acid polymers in F344 rats.” Particle and fibre toxicology vol. 19,1 27. 8 Apr. 2022, doi:10.1186/s12989-022-00468-9

Miura, Yoko et al. “Suppression of epithelial abnormalities by nintedanib in induced-rheumatoid arthritis-associated interstitial lung disease mouse model.” ERJ open research vol. 7,4 00345-2021. 6 Dec. 2021, doi:10.1183/23120541.00345-2021

Miura, Yoko et al. “Bimodal fibrosis in a novel mouse model of bleomycin-induced usual interstitial pneumonia.” Life science alliance vol. 5,1 e202101059. 2 Nov. 2021, doi:10.26508/lsa.202101059

Miyamoto, Hikaru et al. “Acute exacerbation of idiopathic pulmonary fibrosis model by small amount of lipopolysaccharide in rats.” Journal of clinical biochemistry and nutrition vol. 70,2 (2022): 129-139. doi:10.3164/jcbn.21-7

Tomonaga, Taisuke et al. “Examination of Surfactant Protein D as a Biomarker for Evaluating Pulmonary Toxicity of Nanomaterials in Rat.” International journal of molecular sciences vol. 22,9 4635. 28 Apr. 2021, doi:10.3390/ijms22094635

Terasaki, Yasuhiro et al. “Effect of H2 treatment in a mouse model of rheumatoid arthritis-associated interstitial lung disease.” Journal of cellular and molecular medicine vol. 23,10 (2019): 7043-7053. doi:10.1111/jcmm.14603

Urushiyama, Hirokazu et al. “Naftopidil reduced the proliferation of lung fibroblasts and bleomycin-induced lung fibrosis in mice.” Journal of cellular and molecular medicine vol. 23,5 (2019): 3563-3571. doi:10.1111/jcmm.14255

Miura, Yoko et al. “A Subpopulation of Synovial Fibroblasts Leads to Osteochondrogenesis in a Mouse Model of Chronic Inflammatory Rheumatoid Arthritis.” JBMR plus vol. 3,6 e10132. 15 Jan. 2019, doi:10.1002/jbm4.10132

Sisson, Thomas H et al. “Phosphodiesterase 4 inhibition reduces lung fibrosis following targeted type II alveolar epithelial cell injury.” Physiological reports vol. 6,12 (2018): e13753. doi:10.14814/phy2.13753

Sarashina-Kida, Hana et al. “Gallbladder-derived surfactant protein D regulates gut commensal bacteria for maintaining intestinal homeostasis.” Proceedings of the National Academy of Sciences of the United States of America vol. 114,38 (2017): 10178-10183. doi:10.1073/pnas.1712837114

Saito, Atsushi et al. “Modeling pulmonary alveolar microlithiasis by epithelial deletion of the Npt2b sodium phosphate cotransporter reveals putative biomarkers and strategies for treatment.” Science translational medicine vol. 7,313 (2015): 313ra181. doi:10.1126/scitranslmed.aac8577

Fukushi, Masaya et al. “Laninamivir octanoate and artificial surfactant combination therapy significantly increases survival of mice infected with lethal influenza H1N1 Virus.” PloS one vol. 7,8 (2012): e42419. doi:10.1371/journal.pone.0042419

Ilex Life Sciences LLC is an authorized distributor of Yamasa Rat/Mouse SP-D Kit EIA II.